TC BioPharm Investors
TC BioPharm developing safer, cheaper, consistent and durable CAR-T drugs for hematological and solid tumors.
Technology:
Advanced Longevity (R&D)
Headquarters:
Holytown, North Lanarkshire, United Kingdom
Founded Date:
2013
Industry:
Advanced and Next Generation Therapies (Various)
Number Of Exists:
N/A
Employee Number:
11-50
Investor Type:
Healthcare Company









